What is the current stock price of Cardio Diagnostics Holdings, Inc. (CDIO)?

As of the latest market data, Cardio Diagnostics Holdings, Inc. (CDIO) is trading at $1.83. The stock has seen a gain of 1.10% today.

Does Cardio Diagnostics Holdings, Inc. (CDIO) pay a dividend?

Based on current data, Cardio Diagnostics Holdings, Inc. does not have a confirmed active dividend policy.

What is the market cap of Cardio Diagnostics Holdings, Inc.?

The current market capitalization of Cardio Diagnostics Holdings, Inc. (CDIO) is approximately unavailable.

CDIO

Cardio Diagnostics Holdings, Inc.·Healthcare

1.83

1.105%(+0.02)

Market Closed

2.25

22.951%(+0.42)

After Hours

Last Updated: — ET

52W L: $0.9752W H: $17.40

CDIO NEWS

businesswire.com

Feb 18

CORRECTING and REPLACING Cardio Diagnostics Holdings, Inc. to Host Investor Call on Thursday, February 19, 2026

CHICAGO--(BUSINESS WIRE)--Cardio Diagnostics will host an investor conference call on Thursday, February 19, 2026, at 3 p.m. Central Time.

businesswire.com

Feb 17

Cardio Diagnostics Holdings, Inc. to Host Investor Call on Wednesday, February 18, 2026

CHICAGO--(BUSINESS WIRE)--Cardio Diagnostics will host an investor conference call on Wednesday, February 18, 2026, at 3 p.m. Central Time.

defenseworld.net

Jan 13

Reviewing Allarity Therapeutics (NASDAQ:ALLR) & Cardio Diagnostics (NASDAQ:CDIO)

Cardio Diagnostics (NASDAQ: CDIO - Get Free Report) and Allarity Therapeutics (NASDAQ: ALLR - Get Free Report) are both small-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their valuation, earnings, analyst recommendations, institutional ownership, risk, profitability and dividends. Volatility and Risk Cardio Diagnostics has a

Company Profile

Cardio Diagnostics Holdings, Inc. develops and commercializes epigenetics-based clinical tests for cardiovascular disease. It offers Epi+Gen CHD, a three-year symptomatic coronary heart disease risk assessment test. Cardio Diagnostics Holdings, Inc. was founded in 2017 and is based in Chicago, Illinois.

Sector

Healthcare

Industry

Biotechnology

Employees

IPO Date

2022-01-14

Beta

2.66

Websitecardiodiagnosticsinc.com↗